(NASDAQ: CGEN) Compugen's forecast annual revenue growth rate of 32.13% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 78.34%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.8%.
Compugen's revenue in 2025 is $22,144,000.On average, 4 Wall Street analysts forecast CGEN's revenue for 2025 to be $1,154,226,305, with the lowest CGEN revenue forecast at $327,373,750, and the highest CGEN revenue forecast at $2,806,060,710. On average, 3 Wall Street analysts forecast CGEN's revenue for 2026 to be $3,418,062,551, with the lowest CGEN revenue forecast at $935,353,570, and the highest CGEN revenue forecast at $4,676,767,850.
In 2027, CGEN is forecast to generate $4,587,254,513 in revenue, with the lowest revenue forecast at $2,338,383,925 and the highest revenue forecast at $6,279,028,515.